BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 10526754)

  • 1. Effect of troglitazone on lipoprotein(a) levels in obese subjects.
    Tack CJ; Smits P; DeMacker PN; Stalenhoef AF
    Diabetes Care; 1999 Oct; 22(10):1752-3. PubMed ID: 10526754
    [No Abstract]   [Full Text] [Related]  

  • 2. Troglitazone's effect on lipoprotein(a) levels.
    Ovalle F; Bell DS
    Diabetes Care; 1999 May; 22(5):859-60. PubMed ID: 10332700
    [No Abstract]   [Full Text] [Related]  

  • 3. Increase of lipoprotein (a) with troglitazone.
    Matsumoto K; Miyake S; Yano M; Ueki Y; Tominaga Y
    Lancet; 1997 Dec; 350(9093):1748-9. PubMed ID: 9413470
    [No Abstract]   [Full Text] [Related]  

  • 4. Troglitazone reduces plasma levels of tumour necrosis factor-alpha in obese patients with type 2 diabetes.
    Katsuki A; Sumida Y; Murata K; Furuta M; Araki-Sasaki R; Tsuchihashi K; Hori Y; Yano Y; Gabazza EC; Adachi Y
    Diabetes Obes Metab; 2000 Jun; 2(3):189-91. PubMed ID: 11220554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone and small low-density lipoprotein in type 2 diabetes.
    Hirano T; Yoshino G; Kazumi T
    Ann Intern Med; 1998 Jul; 129(2):162-3. PubMed ID: 9669982
    [No Abstract]   [Full Text] [Related]  

  • 6. A treatment for Mr WP: thiazolidinediones after troglitazone.
    Montague CT
    Diabet Med; 2002; 19 Suppl 1():7-9. PubMed ID: 11871423
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone for non-insulin-dependent diabetes mellitus.
    Med Lett Drugs Ther; 1997 May; 39(1001):49-51. PubMed ID: 9164446
    [No Abstract]   [Full Text] [Related]  

  • 9. Learning to use troglitazone.
    Riddle MC
    Diabetes Care; 1998 Sep; 21(9):1389-90. PubMed ID: 9727881
    [No Abstract]   [Full Text] [Related]  

  • 10. Usefulness of troglitazone administration to obese hyperglycaemic patients with near-normoglycaemia.
    Sekino N; Kashiwabara A; Inoue T; Kawasaki T; Ogata N; Sawashige K; Yamanouchi T
    Diabetes Obes Metab; 2003 May; 5(3):145-9. PubMed ID: 12681020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troglitazone: a new antihyperglycemic agent.
    Vidt DG; Speerhas RA; Reddy SS
    Cleve Clin J Med; 1997 May; 64(5):238-40. PubMed ID: 9149473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of troglitazone measured by insulin resistance index.
    Nagasaka S; Iwamoto Y; Ishikawa S; Kuzuya T; Saito T
    Lancet; 1997 Jul; 350(9072):184. PubMed ID: 9250189
    [No Abstract]   [Full Text] [Related]  

  • 13. New diabetes drug targets insulin resistance.
    Am J Health Syst Pharm; 1997 Mar; 54(6):623, 625. PubMed ID: 9075488
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troglitazone prevents and reverses dyslipidemia, insulin secretory defects, and histologic abnormalities in a rat model of naturally occurring obese diabetes.
    Jia DM; Tabaru A; Nakamura H; Fukumitsu KI; Akiyama T; Otsuki M
    Metabolism; 2000 Sep; 49(9):1167-75. PubMed ID: 11016899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New directions in treating insulin resistance.
    Reusch JE
    Hosp Pract (1995); 1995 Sep; 30(9):9-10. PubMed ID: 7559840
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of troglitazone on insulin sensitivity.
    Henry RR
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S148-50. PubMed ID: 8894499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of troglitazone in type 2 diabetes mellitus.
    Gorson DM
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696655
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of troglitazone in type 2 diabetes mellitus.
    Rusk MH
    N Engl J Med; 1998 Aug; 339(6):406. PubMed ID: 9696656
    [No Abstract]   [Full Text] [Related]  

  • 20. [Troglitazone, an insulin action enhancer--a drug of precision to treat adult-onset diabetes].
    Westerbacka J; Yki-Järvinen H
    Duodecim; 1997; 113(19):1847-8. PubMed ID: 10892078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.